Medis has been selling high-quality generic pharmaceuticals to other pharmaceutical companies since 1985.

Medis offers a broad portfolio of 185+ pharmaceutical products covering a broad range of therapeutic areas. We offer multiple dosage forms including immediate and modified release tablets and capsules, soft gel capsules, nasal suspensions, ointments, gels, oral liquids and injectables.

The companies we work with rely on us for pharmaceutical intellectual property. This intellectual property comes in the form of registration dossiers which must meet regulations and guidelines.

Our experience and skills in launching new products and navigating regulations help us achieve quick and successful outcomes. In fact, we have enabled customers to obtain marketing authorizations in 140+ countries.

Fully supported by our parent company, Teva Pharmaceuticals, we leverage their resources and experts for development and manufacturing. We prioritize technical excellence and compliance when handling our customers' confidential information.

At Medis, we aim to build strong and lasting relationships with our customers. We do this by communicating effectively and proactively, and by enhancing their experience throughout their journey with us.

Each customer is assigned a business development manager. This manager assists the customer from the start of contract negotiation until the end of the product's commercial lifecycle.

Each customer also has a customer experience manager. This manager handles all their product orders, queries, and supply-related matters. The customer experience manager is their main point of contact.

Other teams at Medis also contribute to providing the customer with a smooth licensing experience. The launch coordination team ensures everything is ready for a timely launch. The supply chain team manages the flow of goods to customers. Our customers also benefit from dedicated regulatory and serialization support.

Find us at www.medis.is to learn how we can fully support your in-licensing needs.